Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniofacial Abnormalities | 2 | 2014 | 24 | 0.780 |
Why?
|
| Bacteria | 2 | 2020 | 293 | 0.640 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2020 | 90 | 0.620 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 245 | 0.600 |
Why?
|
| Neural Tube | 2 | 2016 | 8 | 0.550 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 432 | 0.490 |
Why?
|
| Encephalocele | 1 | 2014 | 4 | 0.430 |
Why?
|
| Facial Bones | 1 | 2014 | 6 | 0.430 |
Why?
|
| Lipoma | 1 | 2012 | 5 | 0.370 |
Why?
|
| Congenital Abnormalities | 1 | 2012 | 21 | 0.360 |
Why?
|
| Protein-Lysine 6-Oxidase | 6 | 2013 | 69 | 0.350 |
Why?
|
| Mutation | 2 | 2016 | 1177 | 0.350 |
Why?
|
| Military Personnel | 2 | 2024 | 110 | 0.350 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 140 | 0.320 |
Why?
|
| Amino Acid Oxidoreductases | 5 | 2013 | 37 | 0.280 |
Why?
|
| Tropoelastin | 2 | 2007 | 14 | 0.270 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2007 | 26 | 0.260 |
Why?
|
| Lung | 1 | 2007 | 492 | 0.200 |
Why?
|
| Mice | 9 | 2016 | 6644 | 0.180 |
Why?
|
| Epithelial Cells | 3 | 2020 | 434 | 0.180 |
Why?
|
| Mycoplasma genitalium | 1 | 2021 | 3 | 0.180 |
Why?
|
| Mycoplasma Infections | 1 | 2021 | 6 | 0.180 |
Why?
|
| Bacteriological Techniques | 1 | 2020 | 15 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2016 | 300 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2013 | 166 | 0.160 |
Why?
|
| Cell Physiological Phenomena | 1 | 2020 | 9 | 0.160 |
Why?
|
| Electric Impedance | 1 | 2020 | 28 | 0.160 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 51 | 0.160 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2020 | 102 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2014 | 1596 | 0.150 |
Why?
|
| Animals | 11 | 2016 | 16992 | 0.140 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 611 | 0.140 |
Why?
|
| Transcription Factors | 3 | 2016 | 735 | 0.140 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 157 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 1081 | 0.120 |
Why?
|
| Ectoderm | 1 | 2016 | 12 | 0.120 |
Why?
|
| Codon, Nonsense | 1 | 2016 | 23 | 0.120 |
Why?
|
| Homozygote | 1 | 2016 | 77 | 0.120 |
Why?
|
| Body Size | 1 | 2016 | 49 | 0.120 |
Why?
|
| Cell Polarity | 1 | 2016 | 57 | 0.120 |
Why?
|
| Point Mutation | 1 | 2016 | 98 | 0.120 |
Why?
|
| Anencephaly | 1 | 2014 | 4 | 0.110 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2014 | 3 | 0.110 |
Why?
|
| Bone Development | 1 | 2014 | 28 | 0.110 |
Why?
|
| Humans | 14 | 2024 | 43102 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 257 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2004 | 58 | 0.100 |
Why?
|
| Placentation | 1 | 2013 | 8 | 0.100 |
Why?
|
| RNA | 1 | 2016 | 266 | 0.100 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 54 | 0.100 |
Why?
|
| Trophoblasts | 1 | 2013 | 33 | 0.100 |
Why?
|
| PPAR gamma | 1 | 2013 | 55 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 561 | 0.090 |
Why?
|
| Models, Biological | 1 | 2016 | 712 | 0.090 |
Why?
|
| Corpus Callosum | 1 | 2012 | 14 | 0.090 |
Why?
|
| Face | 1 | 2012 | 40 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 245 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2005 | 1070 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 694 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 704 | 0.080 |
Why?
|
| Gestational Age | 2 | 2007 | 200 | 0.070 |
Why?
|
| Mammary Glands, Human | 1 | 2009 | 40 | 0.070 |
Why?
|
| Amine Oxidase (Copper-Containing) | 1 | 2008 | 5 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 587 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 237 | 0.070 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2007 | 4 | 0.070 |
Why?
|
| Biliary Atresia | 1 | 2007 | 7 | 0.070 |
Why?
|
| Immunohistochemistry | 5 | 2009 | 934 | 0.070 |
Why?
|
| Mesoderm | 1 | 2007 | 73 | 0.070 |
Why?
|
| Pancreatic Elastase | 1 | 2007 | 7 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2007 | 972 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2007 | 28 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 216 | 0.060 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 44 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 33 | 0.060 |
Why?
|
| Sheep | 1 | 2007 | 77 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2007 | 21 | 0.060 |
Why?
|
| Fibrosis | 1 | 2007 | 169 | 0.060 |
Why?
|
| Serine | 1 | 2007 | 79 | 0.060 |
Why?
|
| Peroxidase | 1 | 2007 | 57 | 0.060 |
Why?
|
| Superoxide Dismutase | 2 | 2004 | 158 | 0.060 |
Why?
|
| Pregnancy | 2 | 2013 | 1772 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 183 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2007 | 352 | 0.060 |
Why?
|
| Oxygen | 1 | 2007 | 218 | 0.060 |
Why?
|
| Esophageal Neoplasms | 1 | 2007 | 140 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 57 | 0.060 |
Why?
|
| Cell Line | 3 | 2020 | 1410 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 223 | 0.060 |
Why?
|
| Fibronectins | 1 | 2005 | 69 | 0.060 |
Why?
|
| Cadherins | 1 | 2005 | 102 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2005 | 61 | 0.050 |
Why?
|
| Muscle Weakness | 1 | 2004 | 7 | 0.050 |
Why?
|
| Carcinoma | 1 | 2005 | 108 | 0.050 |
Why?
|
| Cyclosporine | 1 | 2004 | 36 | 0.050 |
Why?
|
| Blotting, Western | 4 | 2009 | 883 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2004 | 139 | 0.050 |
Why?
|
| Indonesia | 1 | 2024 | 22 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2007 | 638 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2005 | 189 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2024 | 203 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2004 | 152 | 0.050 |
Why?
|
| Longevity | 1 | 2004 | 173 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 652 | 0.040 |
Why?
|
| Female | 6 | 2021 | 24698 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 269 | 0.040 |
Why?
|
| Chlamydia trachomatis | 1 | 2021 | 70 | 0.040 |
Why?
|
| Microelectrodes | 1 | 2020 | 22 | 0.040 |
Why?
|
| Enterococcus | 1 | 2020 | 8 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2020 | 27 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2020 | 63 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2020 | 94 | 0.040 |
Why?
|
| Azacitidine | 2 | 2009 | 21 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 1723 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2020 | 136 | 0.030 |
Why?
|
| Hawaii | 1 | 2024 | 2011 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1600 | 0.030 |
Why?
|
| Catalysis | 2 | 2009 | 187 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2020 | 460 | 0.030 |
Why?
|
| Glutathione Transferase | 2 | 2008 | 90 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 8214 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 1612 | 0.030 |
Why?
|
| DNA Primers | 2 | 2007 | 294 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2008 | 224 | 0.030 |
Why?
|
| Cytokines | 1 | 2020 | 678 | 0.030 |
Why?
|
| Risk Factors | 1 | 2024 | 3994 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 6081 | 0.030 |
Why?
|
| Male | 5 | 2021 | 23409 | 0.030 |
Why?
|
| Middle Aged | 3 | 2021 | 12222 | 0.030 |
Why?
|
| Aminopropionitrile | 1 | 2013 | 13 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2013 | 20 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2013 | 49 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 296 | 0.020 |
Why?
|
| Placenta | 1 | 2013 | 117 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2004 | 665 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 5080 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 2676 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 13872 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2009 | 33 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2008 | 64 | 0.020 |
Why?
|
| Bone Remodeling | 1 | 2008 | 24 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2008 | 44 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2008 | 114 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 131 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2007 | 21 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2007 | 81 | 0.020 |
Why?
|
| CpG Islands | 1 | 2007 | 109 | 0.020 |
Why?
|
| Rats | 2 | 2005 | 3735 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2005 | 75 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 138 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 127 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 51 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 196 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 197 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2005 | 181 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2005 | 196 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2005 | 283 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 526 | 0.010 |
Why?
|
| Anterior Horn Cells | 1 | 2004 | 5 | 0.010 |
Why?
|
| Lysine | 1 | 2005 | 119 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 310 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 2004 | 59 | 0.010 |
Why?
|
| Hindlimb | 1 | 2004 | 32 | 0.010 |
Why?
|
| RNA Interference | 1 | 2005 | 247 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 256 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 532 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 240 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 153 | 0.010 |
Why?
|
| Substantia Nigra | 1 | 2004 | 52 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 296 | 0.010 |
Why?
|
| Propidium | 1 | 2004 | 20 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 423 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 114 | 0.010 |
Why?
|
| Infant | 1 | 2007 | 1175 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 138 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 695 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 306 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 154 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2005 | 281 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2007 | 1546 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 429 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1124 | 0.010 |
Why?
|
| Motor Activity | 1 | 2004 | 437 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 1082 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 968 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 536 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 1154 | 0.010 |
Why?
|
| Cell Survival | 1 | 2004 | 945 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1271 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 2853 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 1857 | 0.010 |
Why?
|
| Child | 1 | 2007 | 3443 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 1869 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2008 | 2157 | 0.010 |
Why?
|
| Aging | 1 | 2004 | 783 | 0.010 |
Why?
|
| Neurons | 1 | 2004 | 1263 | 0.010 |
Why?
|